Hopes thin for future of Astra&#39;s blood drug
121380
THE future of AstraZenecaâs blood-thinning medicine, Exanta, was thrown into fresh doubt last night after Franceâs leading drugs regulator confirmed that it was reviewing the medicineâs approval status.
550692
NEW YORK - Today at the UBS Global Life Sciences Conference, AtheroGenics was met with pointed skepticism over trial results for its drug, AGI-1067.
451546
Equity markets in Europe were expected to open little changed on Monday, with weakness for drugs stocks likely to dent enthusiasm after downgrades for AstraZeneca following the failure of its Iressa drug, announced on Friday.
401694
A drug called picotamide appears to be a more effective blood-thinner than aspirin for people with diabetes, according to an Italian study.
87010
New data are due out on a promising cholesterol drug. But there are doubters.
115250
A high-dose regimen of Merck&#39;s cholesterol drug Zocor offered no conclusive benefits over a low-cholesterol diet and a lower dose of Zocor in preventing a recurrence of cardiac events
65620
Vertex Pharmaceuticals is losing money. But it has at least one drug that makes the future look brighter.
471279
The Thursday night rejection of Proctor &amp; Gamble&#39;s (PG:NYSE - news - research) female testosterone sex-drive patch Intrinsa by a Food and Drug Administration advisory panel will almost certainly delay efforts by BioSante to develop its own product, a
15055
AstraZeneca Plc (AZN) on Friday said US regulators did not approve its anti-clotting drug Exanta. The US Food and Drug Administration followed the advice of an advisory panel, which last
526962
As worries for its anemia drugs abate, investors will start to worry about Merck and Novartis.
51238
An experimental eye disease drug has been a boon to Eyetech Pharmaceuticals. But as the drug nears approval, many doctors are questioning its effectiveness.
460971
Will AstraZeneca become the latest casualty in the drug safety debate?
310266
Trial results for a drug that controls bleeding include a favorable comparison with a similar product.
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival
13123
UK biotechnology company Cambridge Antibody Technology has announced a five-year alliance with pharmaceutical giant AstraZeneca. CAT said AstraZeneca will make an upfront equity investment in CAT worth Â£75
425170
Faced with weak development pipelines that are putting a drag on stock prices, drug manufacturers are retooling the decades-old system of clinical trials to make it faster and cheaper.
606077
Novartis gets set to market a novel diabetes treatment, with EU approval that is not all it had hoped for.